Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

The purpose of this study is to estimate and compare the incidence of overall malignancy, serious infection, and opportunistic infections between new users of ustekinumab and new users of other biologic therapies among adult participants with Crohn's disease (CD) or ulcerative colitis (UC).

Participants needed: 1,056
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Janssen Scientific Affairs, LLCUpdated: May 8, 2026Locations: 1
Eligibility criteria

Adult men and women with CD or UC who are new users of ustekinumab or the compar... [+1]

Participants below 18 years of age on the exposure index date [+4]

Status: Available

Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma

The purpose of this expanded access program (EAP) is to provide ciltacabtagene autoleucel (cilta-cel) that does not meet the commercial release specifications of CARVYKTI and is not available via the local health care system in the country where the treatment is requested.

Trial details
Age: 18+Biological sex: AllType: Expanded AccessSponsor: Janssen Scientific Affairs, LLCUpdated: Feb 13, 2026Locations: 138
Eligibility criteria

Eligible for treatment with cilta-cel per United States Prescribing Information... [+5]